THE BALANCE

Private admissions

Let’s talk about your next step.

Speak with our admissions team about treatment for you or someone you care about.

Your admissions team

Jil Moore
Jil MooreClient Relations Director
Cynthia Nakhle
Cynthia NakhleAdmissions Manager
Abdullah Boulad, Founder & CEO

Prefer to speak with our founder?

Abdullah Boulad · Founder & CEO

Clinical resource

Buprenorphine Withdrawal

Buprenorphine can cause physical dependence and withdrawal, but prescribed treatment for opioid use disorder reduces cravings and overdose risk. Do not stop it abruptly. Tapering and treatment duration should be individualized with the prescriber, and stopping OUD medication can increase relapse and overdose risk.

Clinically reviewed byDr. Sarah Boss, MD
Stone residence with a swimming pool, lawn and palm trees

Quick Summary

  • Buprenorphine can support opioid recovery, but prolonged or illicit use may lead to dependence and withdrawal when use stops abruptly.
  • Withdrawal can include physical symptoms, anxiety and mood changes. Suicidal thoughts need immediate support; intent to act or inability to stay safe requires emergency help.
  • Withdrawal may be delayed and last for weeks or longer; formulation and taper matter, and severe or worsening symptoms need clinical review.

Buprenorphine is an evidence-based medication used to treat opioid use disorder and, in some formulations, pain. In opioid use disorder treatment it can reduce withdrawal symptoms and cravings and lower the risk of overdose death. Buprenorphine can also cause physical dependence, and misuse can occur, but physical dependence during prescribed treatment is not the same as addiction. Treatment duration is individualized and may be long term or indefinite when benefits continue.

Because buprenorphine is an opioid, regular use can produce physical dependence. Abrupt discontinuation can cause opioid-withdrawal symptoms, so a planned reduction should be discussed with the prescriber. Current FDA labeling recommends gradual tapering when treatment is discontinued. A long half-life affects the timing of withdrawal, but it does not by itself establish addiction.

It is important to remember that not all buprenorphine addiction and withdrawal occur due to its use as a part of opioid addiction recovery assistance. Some people also use this drug illicitly to achieve a recreational high. Physical dependence during prescribed buprenorphine treatment does not by itself require detox. Continued treatment may be appropriate long term; problematic use and any proposed dose reduction require an individual clinical assessment. This prompts a somewhat important question, “what are the common buprenorphine withdrawal symptoms and what to anticipate during its detox?”

Once an individual becomes chemically dependent on buprenorphine, ceasing it suddenly perpetuates a withdrawal. As a partial opioid agonist, buprenorphine leads to the same types of withdrawal symptoms that most other opiates produce upon cessation. These withdrawal symptoms might be mild, moderate, or severe, based on the duration of use, daily dose and frequency, and the preferred mode of administration.

During a withdrawal, the body undergoes a lot of pressure and work. Hence, an individual may expect to experience certain physical and psychological symptoms as they undergo a buprenorphine detox. In some people, certain co-occurring mental health issues may also emerge side by side. Some of the most common Belbuca withdrawal symptoms that primarily affect physical health include:

Hot or Cold Flashes

Individuals undergoing Subutex withdrawal may experience a sudden and intense coldness or heat all over the body.

Skin Abnormalities

A lot of people undergoing buprenorphine detox complain of feeling physically uncomfortable. Some feel like multiple bugs crawling all over their bodies, while others experience goosebumps from time to time.

Tiredness

One of the most common physical buprenorphine withdrawal symptoms is excessive fatigue that interferes with daily life activities.

Muscle Discomfort

This symptom manifests in the form of cramps and pain in different parts of the body.

Increased Cravings

Most people experience both mental and physical cravings for buprenorphine, especially during the initial few days of detox.

Excessive Sweating

Sweating is an autonomic symptom of opioid withdrawal, not a way to flush buprenorphine from the body. Sweating, vomiting, or diarrhea can contribute to dehydration.

Nausea and Vomiting

Nausea and vomiting are the commonest buprenorphine withdrawal symptoms that can make detox unpleasant for many.

Appetite Loss

Due to the multiple side effects of buprenorphine withdrawal, many people find it difficult to eat or drink adequately throughout the detox.

Diarrhea

Loose stools not only make detox uncomfortable but also increases the risk of acquiring dehydration.

Sleep-Related Troubles

As the body is detoxing itself from buprenorphine, many users find it difficult to sleep through the night. This side effect further adds to other issues that an individual faces simultaneously.

Some common psychological symptoms of buprenorphine withdrawal include the following:

Irritability or Moodiness

Irritability or mood changes can occur as the nervous system adapts during withdrawal; they cannot be explained simply as losing an excess of dopamine.

Depression & Suicidality

Depressive symptoms or suicidal thoughts require prompt help, whether or not withdrawal contributes. Contact a mental-health professional or crisis service right away for suicidal thoughts; call local emergency services if there is intent to act or you cannot stay safe.

Anxiety

Anxiety can occur during detox from Subutex, but its duration varies. Seek prompt clinical review for severe, persistent, or worsening anxiety rather than waiting for it to pass.

Miscellaneous Co-occurring Disorders

In addition to anxiety and depression, withdrawal may cause other underlying mental health issues to erupt and rise to the surface. For example, someone using buprenorphine to numb their traumatic past experiences and memories may develop symptoms of posttraumatic stress disorder as soon as they begin to detox. Similarly, many other people who are silently suffering from other co-existing mental disorders may experience a surge in the intensity of these symptoms.

The severity and duration of buprenorphine withdrawal will vary from person to person, and mild withdrawal symptoms can sometimes last several weeks, even after a detox program is over. The periods below are not fixed stages because withdrawal is different for everyone; onset and duration depend on the formulation, dose, duration of treatment, and pace of any taper.

Buprenorphine Withdrawal Timeline

The duration of buprenorphine withdrawal can vary from one person to another. Sublingual products such as Subutex and buccal products such as Belbuca are not interchangeable; timing may differ, particularly with long-acting injections.

24 to 72 Hours

Symptoms may not begin or peak within the first 72 hours because buprenorphine withdrawal can be delayed. Nausea, sweating, diarrhea, restlessness, dilated pupils, and watery eyes can occur, with timing that varies between people.

Week One

During the first week, symptoms may still be emerging or continuing. Cramps, aches, sleep difficulties, and mood changes do not follow a predictable schedule; contact the prescriber if symptoms are severe or worsening.

Week Two

Symptoms may continue beyond two weeks, and improvement varies. Persistent pain, depression, or loss of motivation deserves clinical review rather than an assumption that it is a normal stage.

Week Three to Four

Withdrawal symptoms, cravings, and mood problems can persist for weeks or longer. Risk of return to opioid use is not confined to a particular week; continuing care and overdose prevention remain important.

If a person chooses to reduce buprenorphine after clinical assessment, a gradual, prescriber-led plan can help manage withdrawal. Continuing effective medication is also a valid treatment option. A standard detox program for buprenorphine addiction begins with a detailed evaluation conducted by a medical professional, allowing the rehab center team to determine the best type of treatment required to overcome personal challenges. During this step, a physician may assess how severe an addiction is and formulate a tailored program according to each patient’s needs.

Following the initial evaluation, the clinician and patient decide whether to continue treatment or attempt a gradual dose reduction. Withdrawal symptoms may occur during a reduction, and the plan may need to slow or pause. The intensity and severity of these symptoms largely depend on how much a person is dependent on buprenorphine. Physical dependence does not mean that prescribed treatment is unhealthy. Any taper should allow time for adjustment and reassessment rather than impose a fixed completion date.

Many detox programs provide patients to avail other treatment options, such as group therapy, one-on-one therapy, and recreational therapy, once their symptoms become mild. The specific regimen for each patient depends on what their treatment team deems appropriate for their overall recovery. Continuing care should be arranged before any taper, including follow-up, overdose prevention and access to ongoing or restarted medication when needed. Stopping buprenorphine can increase the risk of return to opioid use and overdose; therapy alone does not guarantee long-term recovery.

Questions

Frequently Asked Questions

How long does buprenorphine withdrawal last?
Buprenorphine withdrawal may be delayed and does not reliably peak within 72 hours or resolve within seven days. Physical symptoms can persist for weeks, and cravings or mood symptoms may last longer. Timing depends on the formulation and taper; severe, persistent, or worsening symptoms require clinical review. The severity of these symptoms and the exact duration of time for which they persist may vary from one person to another based on varying factors, like:
The duration of buprenorphine addiction
The dosage of buprenorphine taken every day
The frequency of use
The level of tolerance and dependence built on buprenorphine
Why is it so important to undergo supervised detox for buprenorphine addiction?
Supervision is important when a dose reduction is chosen, but physical dependence on prescribed buprenorphine does not automatically require detox. For opioid use disorder, treatment may continue long term or indefinitely while beneficial. Discuss any taper with the prescriber, including withdrawal support, follow-up, access to naloxone and the option to continue or restart treatment. Stopping can increase the risk of return to opioid use and overdose.
Can I detox from Subutex at home?
The appropriate setting for a buprenorphine dose reduction depends on the reason for treatment, medical and psychiatric risk, other substance use, housing and support, and the person’s preferences. Many stable patients can be managed as outpatients with prescriber follow-up; residential or hospital care is reserved for situations that require a higher level of support. Do not stop buprenorphine abruptly without discussing the plan with the prescriber. For people taking it for opioid use disorder, discontinuation can increase the risk of return to opioid use and overdose after tolerance falls, so continuing medication may be safer than tapering for some people.

Editorial evidence

Evidence & sources

Selected clinical guidelines, peer-reviewed research, and public-health sources used in this article.

01National Center for Biotechnology Information. (n.d.). Opioid Withdrawal – StatPearls – NCBI Bookshelf.
02Nudges to reason: not guilty. (pubmed.ncbi.nlm.nih.gov).
03National Institute for Health and Care Excellence. (2007). Drug misuse: Opioid detoxification (NICE Guideline CG52).View source
View all 7 sourcesShow fewer sources
04Cochrane. (2017). Buprenorphine for managing opioid withdrawal.View source
05National Institute on Drug Abuse. (2024). Medications to treat opioid use disorder. National Institutes of Health.
06National Institute for Health and Care Excellence. (2022). Medicines associated with dependence or withdrawal symptoms: Safe prescribing and withdrawal management for adults.
07World Health Organization. (2009). Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence.
What this includes
01

Clinical context

Clear information is framed around complex and co-occurring presentations.

02

Individual factors

Assessment remains essential because needs and risks differ from person to person.

03

Next steps

A confidential conversation can help clarify the most appropriate route forward.

Not sure where the situation fits?

Your admissions team

Jil Moore
Jil MooreClient Relations Director
Cynthia Nakhle
Cynthia NakhleAdmissions Manager

A confidential first conversation can help clarify the presentation and whether our setting is appropriate.

THE BALANCE
A PLACE TO BEGIN

Ask about our care